Rush-Presbyterian St. Luke's Medical Center is a clinical research site located in Chicago, Illinois, United States 60612.
Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.
Rush-Presbyterian St. Luke's Medical Center has participated in 7 clinical trials.
Therapeutic areas: Multiple Sclerosis, Relapsing-Remitting, Chronic Heart Failure, Infant, Very Low Birth Weight.
Sponsors: Biogen, Cumberland Pharmaceuticals, Prolacta Bioscience.
Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Rush-Presbyterian St. Luke's Medical Center has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Rush-Presbyterian St. Luke's Medical Center has 7 clinical trials on record. Their work covers Multiple Sclerosis, Relapsing-Remitting, Chronic Heart Failure, Infant, Very Low Birth Weight.
Yes — Rush-Presbyterian St. Luke's Medical Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.